Burning Mouth Syndrome (BMS) Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
- Transparency Market Research
- Healthcare IT
Burning mouth syndrome (BMS) is a medical indication that causes chronic or recurrent sensation of burning and pain in the tongue, roof of the mouth, the gums, and the cheeks. The exact cause of burning mouth syndrome is not yet known. Symptoms of the disease appear suddenly or they may develop gradually over a period of time. The test for exact diagnosis of burning mouth syndrome is yet to be developed, which makes it challenging for physicians to treat the syndrome. The most common symptoms of the burning mouth syndrome are burning or scalding of the mouth, tingling of the mouth, sensation of dry mouth, and loss or change of taste. The pain caused due to BMS shows different patterns. It may occur every day, every month, or every year. BMS may also exhibit a pattern of appearing and disappearing symptoms. Based on cause, BMS can be classified into primary burning mouth syndrome and secondary burning mouth syndrome. No specific treatment or medication has been developed for the treatment of BMS; however, certain medications relive the symptoms.
The global burning mouth syndrome treatment market is projected to be primarily driven by the growing prevalence and incidence of BMS across the world. Studies have shown that women are 3–7 times more prone to BMS than men. The disease develops mostly after the age of 50. As this disease mostly occurs in elderly people, rapidly growing elderly population in developed countries such as the U.S., the U.K., and Japan is projected to be a key driver for the BMS treatment market in these countries during the forecast period. Moreover, the rising R&D investment for development of therapeutic drugs for BMS and development and launch of new products proposed in the near future are projected to fuel the worldwide demand for BMS therapeutic drugs in the next few years. On the other hand, lack of standard diagnostic methods or tests and poor understanding about causes of the disease are projected to restrain the BMS treatment market during the forecast period.
The global BMS treatment market can be segmented based on cause of disease, drug class, distribution channel, and geography. Based on cause of disease, the burning mouth syndrome treatment market has been classified into primary burning mouth syndrome and secondary burning mouth syndrome. In primary burning mouth syndrome, no clinical or diagnostic abnormalities are observed after tests. Secondary burning mouth syndrome is basically caused by underlying medical conditions. The secondary burning mouth syndrome segment is projected to account for a leading share of the global market by 2025. In terms of drug class, the market can be segmented into benzodiazepines, tricyclic antidepressants, miscellaneous topical agents, and others. In terms of distribution channel, the market has been divided into hospital pharmacy, retail pharmacy, and e-commerce. The retail pharmacy segment is estimated to dominate the global market by 2025.
Geographically, the global burning mouth syndrome treatment market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are likely to account for a significant share of the global market by 2025. The large share held by these regions is attributable to rapidly growing geriatric population and well-established health care facilities in these regions. The market in Asia Pacific is projected to witness significant growth during the forecast period, owing to large population in India and China and large geriatric population in Japan. The markets in Latin America and Middle East & Africa region are estimated to expand at moderate CAGRs during the forecast period.
Key players operating in the global burning mouth syndrome treatment market are Baxter International Inc., Mylan Pharmaceuticals Inc., Akorn Consumer Health, Teva Pharmaceutical Industries Ltd., Apotex Corp., Sandoz Inc. (Novartis AG), Fresenius Kabi AG, Genentech, Inc. (F. Hoffmann-La Roche Ltd.), and Pfizer Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Healthcare IT
Healthcare ITGlobal mHealth Market Research Report 2016
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017